Ken Declerck

1.8k total citations
27 papers, 813 citations indexed

About

Ken Declerck is a scholar working on Molecular Biology, Immunology and Complementary and alternative medicine. According to data from OpenAlex, Ken Declerck has authored 27 papers receiving a total of 813 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Immunology and 6 papers in Complementary and alternative medicine. Recurrent topics in Ken Declerck's work include Epigenetics and DNA Methylation (7 papers), Atherosclerosis and Cardiovascular Diseases (3 papers) and Neuroinflammation and Neurodegeneration Mechanisms (2 papers). Ken Declerck is often cited by papers focused on Epigenetics and DNA Methylation (7 papers), Atherosclerosis and Cardiovascular Diseases (3 papers) and Neuroinflammation and Neurodegeneration Mechanisms (2 papers). Ken Declerck collaborates with scholars based in Belgium, France and United States. Ken Declerck's co-authors include Wim Vanden Berghe, Katarzyna Szarc vel Szic, Melita Vidaković, Guy Van Camp, Karen Heyninck, Sabine A. S. Langie, Patrick De Boever, Dragan Milenković, Clarissa Gerhäuser and Gudrun Koppen and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Scientific Reports.

In The Last Decade

Ken Declerck

26 papers receiving 791 citations

Peers

Ken Declerck
Ken Declerck
Citations per year, relative to Ken Declerck Ken Declerck (= 1×) peers Katarzyna Szarc vel Szic

Countries citing papers authored by Ken Declerck

Since Specialization
Citations

This map shows the geographic impact of Ken Declerck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Declerck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Declerck more than expected).

Fields of papers citing papers by Ken Declerck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Declerck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Declerck. The network helps show where Ken Declerck may publish in the future.

Co-authorship network of co-authors of Ken Declerck

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Declerck. A scholar is included among the top collaborators of Ken Declerck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Declerck. Ken Declerck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Milenković, Dragan, Ana Rodriguez‐Mateos, Geoffrey Istas, et al.. (2022). Flavanol Consumption in Healthy Men Preserves Integrity of Immunological‐Endothelial Barrier Cell Functions: Nutri(epi)genomic Analysis. Molecular Nutrition & Food Research. 66(21). e2100991–e2100991. 15 indexed citations
2.
Declerck, Ken, et al.. (2021). Immune checkpoint CD155 promoter methylation profiling reveals cancer-associated behaviors within breast neoplasia. Cancer Immunology Immunotherapy. 71(5). 1139–1155. 4 indexed citations
3.
Hernández, Ivones, Idania Rodeiro, Ken Declerck, et al.. (2021). Marine Seagrass Extract of Thalassia testudinum Suppresses Colorectal Tumor Growth, Motility and Angiogenesis by Autophagic Stress and Immunogenic Cell Death Pathways. Marine Drugs. 19(2). 52–52. 18 indexed citations
4.
Hernández, Ivones, Ken Declerck, Claudina Pérez-Novo, et al.. (2021). Antiproliferative, Antiangiogenic, and Antimetastatic Therapy Response by Mangiferin in a Syngeneic Immunocompetent Colorectal Cancer Mouse Model Involves Changes in Mitochondrial Energy Metabolism. Frontiers in Pharmacology. 12. 670167–670167. 12 indexed citations
5.
Declerck, Ken & Wim Vanden Berghe. (2019). Characterization of Blood Surrogate Immune-Methylation Biomarkers for Immune Cell Infiltration in Chronic Inflammaging Disorders. Frontiers in Genetics. 10. 1229–1229. 11 indexed citations
7.
Milenković, Dragan, Ken Declerck, Zohar Kerem, et al.. (2019). (−)-Epicatechin metabolites promote vascular health through epigenetic reprogramming of endothelial-immune cell signaling and reversing systemic low-grade inflammation. Biochemical Pharmacology. 173. 113699–113699. 33 indexed citations
9.
Milenković, Dragan, Wim Vanden Berghe, Christine Morand, et al.. (2018). A systems biology network analysis of nutri(epi)genomic changes in endothelial cells exposed to epicatechin metabolites. Scientific Reports. 8(1). 15487–15487. 30 indexed citations
10.
Declerck, Ken & Wim Vanden Berghe. (2018). Back to the future: Epigenetic clock plasticity towards healthy aging. Mechanisms of Ageing and Development. 174. 18–29. 65 indexed citations
11.
Ramírez-Sánchez, Jeney, Dariusz Ratman, Claudina Pérez-Novo, et al.. (2017). Semi-synthetic sapogenin exerts neuroprotective effects by skewing the brain ischemia reperfusion transcriptome towards inflammatory resolution. Brain Behavior and Immunity. 64. 103–115. 2 indexed citations
12.
Szic, Katarzyna Szarc vel, et al.. (2017). Epigenetic silencing of triple negative breast cancer hallmarks by Withaferin A. Oncotarget. 8(25). 40434–40453. 51 indexed citations
13.
Istas, Geoffrey, Ken Declerck, Katarzyna Szarc vel Szic, et al.. (2017). Identification of differentially methylated BRCA1 and CRISP2 DNA regions as blood surrogate markers for cardiovascular disease. Scientific Reports. 7(1). 5120–5120. 39 indexed citations
14.
Declerck, Ken, Sylvie Rémy, Christine Wohlfahrt‐Veje, et al.. (2017). Interaction between prenatal pesticide exposure and a common polymorphism in the PON1 gene on DNA methylation in genes associated with cardio-metabolic disease risk—an exploratory study. Clinical Epigenetics. 9(1). 35–35. 29 indexed citations
15.
Chirumamilla, Chandra Sekhar, Ajay Palagani, Balu Kamaraj, et al.. (2017). Selective Glucocorticoid Receptor Properties of GSK866 Analogs with Cysteine Reactive Warheads. Frontiers in Immunology. 8. 1324–1324. 12 indexed citations
16.
Langie, Sabine A. S., Katarzyna Szarc vel Szic, Ken Declerck, et al.. (2016). Whole-Genome Saliva and Blood DNA Methylation Profiling in Individuals with a Respiratory Allergy. PLoS ONE. 11(3). e0151109–e0151109. 42 indexed citations
17.
Langie, Sabine A. S., Matthieu Moisse, Ken Declerck, et al.. (2016). Salivary DNA Methylation Profiling: Aspects to Consider for Biomarker Identification. Basic & Clinical Pharmacology & Toxicology. 121(S3). 93–101. 60 indexed citations
18.
Szic, Katarzyna Szarc vel, Ken Declerck, Melita Vidaković, & Wim Vanden Berghe. (2015). From inflammaging to healthy aging by dietary lifestyle choices: is epigenetics the key to personalized nutrition?. Clinical Epigenetics. 7(1). 33–33. 142 indexed citations
19.
Waumans, Yannick, Gwendolyn Vliegen, Miche Rombouts, et al.. (2015). The Dipeptidyl Peptidases 4, 8, and 9 in Mouse Monocytes and Macrophages: DPP8/9 Inhibition Attenuates M1 Macrophage Activation in Mice. Inflammation. 39(1). 413–424. 29 indexed citations
20.
Szic, Katarzyna Szarc vel, Ken Op de Beeck, Dariusz Ratman, et al.. (2014). Pharmacological Levels of Withaferin A (Withania somnifera) Trigger Clinically Relevant Anticancer Effects Specific to Triple Negative Breast Cancer Cells. PLoS ONE. 9(2). e87850–e87850. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026